Navigation Links
Jennerex Appoints Bob Ingram Special Advisor and Hires Marty Glick as EVP, Corporate Strategy

SAN FRANCISCO, Nov. 8 /PRNewswire/ -- Jennerex, Inc. today announced the addition of Mr. Robert A. Ingram as Special Advisor to the Chairman and to The President & CEO, and the hiring of Mr. Marty Glick as Executive Vice President, Corporate Strategy.

Bob Ingram is Vice Chairman, Pharmaceuticals at GlaxoSmithKline (plc), and previously served as Chief Executive Officer, Chief Operating Officer and President of Pharmaceutical operations for Glaxo Wellcome. Mr. Ingram is Chairman of the Board of Directors of OSI Pharmaceuticals, Inc. and Valeant Pharmaceuticals International, and a member of the Board of Directors of Allergan, Inc., Lowe's Companies, Edwards Lifesciences Corporation, and Wachovia Corporation.

"We are delighted to welcome Bob to the Jennerex team. His experience in leading companies which have successfully developed and commercialized major new medicines adds significant strategic depth to our team," said Brennan Mulcahy, Chairman of Jennerex.

"I am excited to work with the Board and CEO of Jennerex to develop and commercialize a new class of biotherapeutics for the treatment of several major types of cancer," said Bob Ingram.

"We know Bob's extensive pharmaceutical leadership experience will be invaluable to Jennerex as we leverage our innovative technology platform to develop and commercialize major new medicines to treat patients with serious unmet needs in oncology, including liver cancer, melanoma and lung cancer," said David H. Kirn, M.D., President and Chief Executive Officer.

Mr. Glick was Executive Vice President and Chief Financial Officer of Theravance, Inc. until 2005. He led the efforts to successfully raise over $350 million of private and public equity and to form an innovative strategic alliance with GlaxoSmithKline. Prior to Theravance, Mr. Glick held the position of Vice President Finance at Genentech Inc where he was involved in structuring major deals such as in-licensing of Rituxan(R) from Idec (now Biogen Idec). Marty was also a co-founder and Board member of Eyetech Pharmaceuticals.

"Marty's experience in working with top management to successfully finance and build emerging biopharmaceutical companies is an important addition to our team as we drive our lead product candidate toward late stage clinical development and commercialization," said Dr. Kirn.

About Jennerex

Jennerex Biotherapeutics is a clinical stage biotherapeutics company working to create, develop and commercialize first-in-class cancer products. Our products are engineered viruses that have been modified to be safe and effective against various forms of cancer. Jennerex products kill cancer by targeting, attacking and eradicating cancer cells. Our lead product candidate, JX-594, has demonstrated clear anti-cancer effects in a Phase 1 study in patients with late-stage liver cancer. Jennerex has initiated a Phase 2a clinical trial in the U.S., for liver cancer and is currently enrolling a Phase 2a clinical trial at several sites in the U.S. for metastatic melanoma. Jennerex is also planning a Phase 1 study with IV administration focusing on lung cancer and melanoma.

For more information about Jennerex, please visit

SOURCE Jennerex, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
2. Codexis Appoints Singapore Laboratories Managing Director
3. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
4. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
5. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
6. NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection
7. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
8. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
9. NeurogesX Appoints New Director to the Board
10. Alba Therapeutics Appoints Dr. Betsy Van Parijs as Its Senior Vice President, Clinical Development and Medical Affairs
11. Premier Research Appoints Melissa Jones as Vice President, International Business Development
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016 A person commits ... the crime scene to track the criminal down. ... U.S. Food and Drug Administration (FDA) uses DNA evidence to ... Sound far-fetched? It,s not. The FDA has ... to support investigations of foodborne illnesses. Put as simply as ...
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... , June 23, 2016  Blueprint Bio, a company ... to the medical community, has closed its Series A ... Nunez . "We have received a commitment ... capital we need to meet our current goals," stated ... us the runway to complete validation on the current ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity Products, ... tools designed, tuned and optimized exclusively for Okuma CNC machining centers at The ... of a collaboration among several companies with expertise in toolholding, cutting tools, machining ...
Breaking Biology Technology:
(Date:6/22/2016)... BETHESDA, Md. , June 22, 2016  The American ... by Trade Show Executive Magazine as one of ... Summit on May 25-27 at the Bellagio in ... based on the highest percentage of growth in each of ... number of exhibiting companies and number of attendees. The 2015 ...
(Date:6/20/2016)... Securus Technologies, a leading provider of ... safety, investigation, corrections and monitoring announced that after ... secured the final acceptance by all three (3) ... Systems (MAS) installed. Furthermore, Securus will have contracts ... by October, 2016. MAS distinguishes between legitimate wireless ...
(Date:6/9/2016)... , June 9, 2016 ... deploy Teleste,s video security solution to ensure the safety of ... during the major tournament Teleste, an ... systems and services, announced today that its video security solution ... to back up public safety across the country. The ...
Breaking Biology News(10 mins):